Literature DB >> 19447324

Racial differences in women who have a hysterectomy for benign conditions.

Gerson Weiss1, Dorette Noorhasan, Laura L Schott, Lynda Powell, John F Randolph, Janet M Johnston.   

Abstract

OBJECTIVE: To evaluate if there are racial differences between African-American and Caucasian women who have hysterectomy for benign conditions in terms of (1) presenting symptoms (prolapse, vaginal bleeding, pain, and known history of leiomyomas), (2) serum estradiol and testosterone levels at the visit before hysterectomy, and (3) uterine weight.
METHODS: A multi-ethnic, multisite, community-based longitudinal cohort study of 3,302 women ages 42-52 at enrollment was conducted. During 9 years of follow-up, 203 African-American and Caucasian women reported a hysterectomy, 90 with evidence of uterine leiomyomas. Women were surveyed regarding their overall perceived health before and after hysterectomy, presenting symptoms, and their motivations for surgery. Serum estradiol and testosterone levels were measured. Uterine weight at time of hysterectomy and clinical pathology were determined via medical record abstraction.
RESULTS: Previously diagnosed leiomyomas were presenting symptoms more frequently in African-American women than Caucasian women (85% vs. 63%; p = .02). African-American women had less prolapse than Caucasian women (0% vs. 10%; p = 0.04). Chronic pain was a more frequent reason for hysterectomy in African-American women than in Caucasian women (49% vs. 29%; p = .05). There were no differences between the groups in levels of estradiol or testosterone. African-American women had almost twice the uterine weight as that of Caucasian women (448 vs. 240 g; p = .0005).
CONCLUSION: Racial differences in frequency of hysterectomy for benign conditions are consistent with differences in presenting symptoms, where African-American women seemingly have larger, more symptomatic fibroids.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19447324      PMCID: PMC3786579          DOI: 10.1016/j.whi.2009.03.001

Source DB:  PubMed          Journal:  Womens Health Issues        ISSN: 1049-3867


  30 in total

1.  Racial differences in the structure and function of the stress urinary continence mechanism.

Authors:  D Howard; J O Delancey; R Tunn; J A Ashton-Miller
Journal:  Obstet Gynecol       Date:  2000-05       Impact factor: 7.661

2.  Ultrasensitive semiautomated chemiluminescent immunoassay for estradiol.

Authors:  Barry G England; George H Parsons; Russell M Possley; Daniel S McConnell; A Rees Midgley
Journal:  Clin Chem       Date:  2002-09       Impact factor: 8.327

3.  The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters.

Authors:  Karen L Huyck; Carolien I M Panhuysen; Karen T Cuenco; Jingmei Zhang; Hilary Goldhammer; Emlyn S Jones; Priya Somasundaram; Allison M Lynch; Bernard L Harlow; Hang Lee; Elizabeth A Stewart; Cynthia C Morton
Journal:  Am J Obstet Gynecol       Date:  2008-02       Impact factor: 8.661

4.  Testosterone concentrations in women aged 25-50 years: associations with lifestyle, body composition, and ovarian status.

Authors:  M F Sowers; J L Beebe; D McConnell; J Randolph; M Jannausch
Journal:  Am J Epidemiol       Date:  2001-02-01       Impact factor: 4.897

5.  Aromatase activity in uterine leiomyomata.

Authors:  E J Folkerd; C J Newton; K Davidson; M C Anderson; V H James
Journal:  J Steroid Biochem       Date:  1984-05       Impact factor: 4.292

6.  delta 4-3-Ketosteroid 5 alpha-oxidoreductase in human uterine leiomyoma.

Authors:  V V Reddy; L I Rose
Journal:  Am J Obstet Gynecol       Date:  1979-10-01       Impact factor: 8.661

7.  The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata.

Authors:  James B Spies; Karin Coyne; Noureddine Guaou Guaou; Deneane Boyle; Kerry Skyrnarz-Murphy; Sheila M Gonzalves
Journal:  Obstet Gynecol       Date:  2002-02       Impact factor: 7.661

8.  Anthropometric characteristics and risk of uterine leiomyoma.

Authors:  Kathryn L Terry; Immaculata De Vivo; Susan E Hankinson; Donna Spiegelman; Lauren A Wise; Stacey A Missmer
Journal:  Epidemiology       Date:  2007-11       Impact factor: 4.822

9.  High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.

Authors:  Donna Day Baird; David B Dunson; Michael C Hill; Deborah Cousins; Joel M Schectman
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

10.  Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort.

Authors:  Guri Rortveit; Jeanette S Brown; David H Thom; Stephen K Van Den Eeden; Jennifer M Creasman; Leslee L Subak
Journal:  Obstet Gynecol       Date:  2007-06       Impact factor: 7.661

View more
  16 in total

1.  Prevalence of uterine leiomyomas in lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-Dasilva; Antoinette Rabel; Bernadette R Gochuico; Nilo A Avila; Joel Moss
Journal:  Fertil Steril       Date:  2011-09       Impact factor: 7.329

2.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

3.  Reported symptoms before and one year after hysterectomy in African American and white women.

Authors:  Patricia G Moorman; Joellen M Schildkraut; Evan R Myers; Frances Wang
Journal:  J Womens Health (Larchmt)       Date:  2011-06-14       Impact factor: 2.681

Review 4.  Medical treatment of uterine leiomyoma.

Authors:  Mohamed Sabry; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2012-02-28       Impact factor: 3.060

Review 5.  Endocrine-disrupting chemicals and uterine fibroids.

Authors:  Tiffany A Katz; Qiwei Yang; Lindsey S Treviño; Cheryl Lyn Walker; Ayman Al-Hendy
Journal:  Fertil Steril       Date:  2016-08-21       Impact factor: 7.329

6.  Development of an algorithm to assess unmeasured symptom severity in gynecologic care.

Authors:  Kemi M Doll; Annie Green Howard; Till Stürmer; Tim Carey; Wanda K Nicholson; Erin Carey; Evan Myers; David Nerenz; Whitney R Robinson
Journal:  Am J Obstet Gynecol       Date:  2021-11-06       Impact factor: 8.661

7.  Circulating Sex Hormones and Risk of Uterine Fibroids: Study of Women's Health Across the Nation (SWAN).

Authors:  Jason Y Y Wong; Ellen B Gold; Wesley O Johnson; Jennifer S Lee
Journal:  J Clin Endocrinol Metab       Date:  2015-12-15       Impact factor: 5.958

Review 8.  Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids?

Authors:  Md Soriful Islam; Most Mauluda Akhtar; Andrea Ciavattini; Stefano Raffaele Giannubilo; Olga Protic; Milijana Janjusevic; Antonio Domenico Procopio; James H Segars; Mario Castellucci; Pasquapina Ciarmela
Journal:  Mol Nutr Food Res       Date:  2014-06-30       Impact factor: 5.914

Review 9.  The health disparities of uterine fibroid tumors for African American women: a public health issue.

Authors:  Heba M Eltoukhi; Monica N Modi; Meredith Weston; Alicia Y Armstrong; Elizabeth A Stewart
Journal:  Am J Obstet Gynecol       Date:  2013-08-11       Impact factor: 8.661

10.  Racial/Ethnic Differences in the Risk of Surgical Complications and Posthysterectomy Hospitalization among Women Undergoing Hysterectomy for Benign Conditions.

Authors:  Lisa M Pollack; Jerry L Lowder; Matt Keller; Su-Hsin Chang; Sarah J Gehlert; Margaret A Olsen
Journal:  J Minim Invasive Gynecol       Date:  2021-01-01       Impact factor: 4.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.